RIVM formulates criteria for R&D of sustainable pharmaceuticals As part of an international research project, RIVM has formulated criteria for R&D of sustainable new pharmaceuticals. These GREENER criteria are an important first step to develop pharmaceuticals that do not impact the environment..
Hardly any decrease in overweight, smoking and alcohol use since 2018 In 2021 half of all adults were overweight. 21% sometimes smoked, 7% were excessive drinkers and 8% heavy drinkers.
RIVM calls for increased involvement of scientific community in solving plastic crisis Industry and policymakers are not availing themselves enough of the available scientific knowledge when it comes to smarter ways of dealing with plastics.
New: NEVO online 2021 RIVM published a new online edition of the Dutch food composition database (NEVO).
The 13-week scan now available for pregnant women Since 1 September, pregnant women in the Netherlands can have an early ultrasound scan to detect physical abnormalities in their unborn child: the 13-week scan.
Method for safe and sustainable recycling of waste The method developed by RIVM to assess whether waste treatment is sufficiently safe and sustainable, can contribute to the European ambitions for a safe and more circular economy.
A guide for the safe reuse of diaper and incontinence materials RIVM has developed a step-by-step plan for the safe reuse of diapers and incontinence material. This plan provides recyclers and licensing authorities with tools to carry out a risk assessment.
Emphasising safety and sustainability in circular design A stronger focus on safety, health and sustainability is needed in designing circular products. When basic resources are re-used in new products, health risks should be avoided.
iGEM meetup for teams and supervisors The best synbio projects, including iGEM teams, have one thing in common: cutting edge science in the light of carefully considered societal needs.
Teen vaccination against meningococcal disease starts From mid-September, young people born between 1 May and 31 December 2004 will receive an invitation for a vaccination against meningococcal disease.